These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Polymorphism of the E-cadherin gene CDH1 is associated with susceptibility to vitiligo. Tarlé RG; Silva de Castro CC; do Nascimento LM; Mira MT Exp Dermatol; 2015 Apr; 24(4):300-2. PubMed ID: 25613741 [TBL] [Abstract][Full Text] [Related]
7. The genetics of generalized vitiligo and associated autoimmune diseases. Spritz RA Pigment Cell Res; 2007 Aug; 20(4):271-8. PubMed ID: 17630960 [TBL] [Abstract][Full Text] [Related]
8. The Genetic Basis of Vitiligo. Spritz RA; Santorico SA J Invest Dermatol; 2021 Feb; 141(2):265-273. PubMed ID: 32778407 [TBL] [Abstract][Full Text] [Related]
9. New insights into immune mechanisms of vitiligo. Boniface K; Taïeb A; Seneschal J G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930 [TBL] [Abstract][Full Text] [Related]
10. The genetics of generalized vitiligo and associated autoimmune diseases. Spritz RA J Dermatol Sci; 2006 Jan; 41(1):3-10. PubMed ID: 16289692 [TBL] [Abstract][Full Text] [Related]
11. Cytokines: the yin and yang of vitiligo pathogenesis. Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555 [TBL] [Abstract][Full Text] [Related]
12. Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis. Spritz RA J Invest Dermatol; 2012 Feb; 132(2):268-73. PubMed ID: 21993561 [TBL] [Abstract][Full Text] [Related]
13. Vitiligo: pathogenetic hypotheses and targets for current therapies. Guerra L; Dellambra E; Brescia S; Raskovic D Curr Drug Metab; 2010 Jun; 11(5):451-67. PubMed ID: 20540698 [TBL] [Abstract][Full Text] [Related]
14. Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes. Shajil EM; Chatterjee S; Agrawal D; Bagchi T; Begum R Indian J Exp Biol; 2006 Jul; 44(7):526-39. PubMed ID: 16872041 [TBL] [Abstract][Full Text] [Related]
15. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy. Boniface K; Seneschal J; Picardo M; Taïeb A Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247 [TBL] [Abstract][Full Text] [Related]
16. Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs. Alkhateeb A; Qarqaz F Arch Dermatol Res; 2010 Oct; 302(8):631-4. PubMed ID: 20574744 [TBL] [Abstract][Full Text] [Related]
17. Evidence for an autoimmune pathogenesis of vitiligo. Ongenae K; Van Geel N; Naeyaert JM Pigment Cell Res; 2003 Apr; 16(2):90-100. PubMed ID: 12622785 [TBL] [Abstract][Full Text] [Related]
18. Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. Toosi S; Orlow SJ; Manga P J Invest Dermatol; 2012 Nov; 132(11):2601-9. PubMed ID: 22696056 [TBL] [Abstract][Full Text] [Related]
19. Vitiligo: interplay between oxidative stress and immune system. Laddha NC; Dwivedi M; Mansuri MS; Gani AR; Ansarullah M; Ramachandran AV; Dalai S; Begum R Exp Dermatol; 2013 Apr; 22(4):245-50. PubMed ID: 23425123 [TBL] [Abstract][Full Text] [Related]
20. Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff. Boissy RE; Spritz RA Exp Dermatol; 2009 Jul; 18(7):583-5. PubMed ID: 19320739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]